850879-09-3 Usage
Description
N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide is a complex organic compound with a unique chemical structure that features a benzodioxole moiety, a benzofuro[3,2-d]pyrimidine core, and a piperazinecarbothioamide group. N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide is characterized by its potential biological activity and may have applications in various fields, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide is used as a potential therapeutic agent for targeting specific biological pathways and receptors. Its unique structure allows it to interact with cellular targets, making it a candidate for the development of new drugs to treat various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, this compound serves as a valuable research tool for understanding the structure-activity relationships of biologically active molecules. Its synthesis and modification can provide insights into the design of more effective and selective drugs.
Used in Drug Discovery:
N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide is used in drug discovery processes to identify novel lead compounds with potential therapeutic applications. Its unique chemical features can be exploited to develop new drugs with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 850879-09-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,8,7 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 850879-09:
(8*8)+(7*5)+(6*0)+(5*8)+(4*7)+(3*9)+(2*0)+(1*9)=203
203 % 10 = 3
So 850879-09-3 is a valid CAS Registry Number.
InChI:InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)
850879-09-3Relevant articles and documents
PROTEIN KINASE INHIBITORS
-
Page/Page column 62-63, (2008/06/13)
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure (I) including steroisomers, prodrugs and pharmaceutica